Synbio International Inc (ID) (SYIN)

Pos scam still dumping, no bid looming

I guess we're gonna have to agree to disagree, only thing management seems serious abput is selling shares, diluting da shit out this pos turd pig.

Looks like they are done selling shares into the bid. My $$$ cleared a day late. Still picked up some at 8. A grand price for a penny with only 400m shares and serious management.

Looks like this turd headed to no bid

Pos done stick a fork in it

Not good either with all the so called stuff they got going on.

FacialDx CEO Doug Benoit.
https://www.vuelab.com/medtech-founders-club/doug-benoit

New Podcast with Benoit.

https://www.linkedin.com/posts/vuelabinc_medtech-medicaldevices-healthtech-activity-7478196171543572480-5BXS

The OS has only changed here by approximately 90 million since last August.   That’s not too bad.  

I see 1 or 2 things happening & I hope Im incorrect about both R/S or A/S increase.

Waiting for cash to free up. Eights look tasty. Thought 9s would be the low with this share structure.

What, about 20m shares? ~5% of their share base? They still have only 411m shares issued, which for an otc stock is quite low.

They diluting crazy not a good look

Boy they issuing shares crazy.

That's why they are in the process of doing something with it.

"Synbio has signed a Master Services Agreement with a leading Australian clinical research organization, CRO Services Pty Ltd, a wholly owned subsidiary of ASX-listed Resonance Health Ltd (ASX: RHT).

"Under the agreement, Resonance will conduct a proof-of-concept clinical trial to assess the efficacy of FacialDx Incorporated (FacialDx) NIMSTM(Non-invasive Medical Screening) technology and evaluate its performance in real-world clinical conditions."
_____

"Synbio International Inc. (OTC: SYIN) today announced that the Company has been approved for Deposit/Withdrawal at Custodian (DWAC) and Direct Registration System (DRS) processing through its transfer agent, Pacific Stock Transfer Company."
_____

"The company is poised to launch an anti-anxiety product - the first of its nutritional supplements that can aid the long-term management of anxiety. The formula was scientifically designed as an active dietary supplement to nutritionally support the body’s inherent abilities to positively respond to stressful conditions. It will address the needs of the great many people who are searching for natural supplements that may help address symptoms associated with their anxiety."
_____

So whatever. If you don't like the prospects of $SYIN, sell it. But don't just randomly & vaguely talk smack. While $SYIN is still development stage (duh), it's not like it's sitting in some vacuum doing nothing.

Dont mean squat if they aint gonna do nothing with it

390m shares on an OTC? I'll take that any time.

Where, I see they're actively diluting this turd

I've read clearing up debt. Hopefully trials are already paid for.

😀

Shidd more than 17 million added, you think they clearing out that $72k debt or diluting for the fuck of it?

Claudio sued his own company and reached a settlement to be paid in SYIN shares.

“Upon the completion of
the court process and issuance of shares, the applicable liabilities will be extinguished, thereby strengthening the
Company’s working capital position and reducing overall indebtedness. While the issuance of shares will be dilutive to
existing shareholders, management believes the transaction improves the Company’s financial condition by
converting outstanding obligations into equity and removing current and non-current liabilities. The Company believes
the Settlement Agreement resolves outstanding obligations and will result in the conversion of such obligations into
equity securities. The Company does not expect the outcome of this matter to have a material adverse effect on its
liquidity or continuing operations.”

Interesting….
https://trellis.law/case/12011/cace26001912/giacinto-c-solitario-et-al-vs-synbio-international-inc

$SYIN - could be but how are they paying for filings, for the trials in Australia?

Did they flood the market with shares?

They didn't so maybe we see some more shares in the market, that could happen. Either they get approval for their facial recognition product or they don't.

There isn't anything to suggest they are going to flood the market with shares. And if this was just dump, then who was the buyer that took it all in?

Dilution likely occurring. Around 17MM shares added to OS count in recent days.
https://www.otcmarkets.com/stock/SYIN/security

$SYIN - I'm guessing you got your answer yesterday. Just in case some missed the message.

Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.

Someone clearly dumped something like 7 million shares, if the company was an OTCQB they would have been more transparent.

I've had this happen to other OTCIQ stocks and depending on the issue, it could be lifted in a few days.

From OTCID back to Pink Limited again. What’s the deal?

5 million shares added to restricted share count, wonder whats up, something telling me to grab a few shares.

$SYIN - The company put out a PR on January 23rd.

$SYIN -Synbio is overseeing the trial under its clinical and regulatory leadership pursuant to its agreement with FacialDx, the developer of the underlying AI technology. The trial is expected to commence in early 2026 and conclude later in the year.

The last 5 words of that PR tells when the trial will conclude. "LATER IN THE YEAR"

"The study will assess accuracy, reliability, and clinical utility in real-world conditions—data that may support future regulatory submissions and accelerate commercialization efforts. Conducting the trial in Australia offers cost and timeline efficiencies while maintaining globally recognized clinical and ethical standards."

"The company entered into a Master Services Agreement with CRO Services Pty Ltd, a leading Australian clinical research organization and a wholly owned subsidiary of Resonance Health Ltd (ASX: RHT). Under the agreement, CRO Services will conduct a clinical study to evaluate the real-world performance of FacialDx Incorporated’s NIMS™ (Non-invasive Medical Screening) platform, a proprietary AI-based facial analysis technology."

I looked up CRO Services trials and they are shorter than the normal "clinical trials" we would have in the US. My understanding, which seems to be corroborated by the January 23rd PR is that these can take anywhere from 4 months to 6 months.

The good news...these trials are shorter than those in the US, but Australia has reciprocity agreements with both the US and Europe. That means the triial in any of those jurisdictions ias accepted as valid by the other two. So if their trial in Australia is successful, they would have access to both the US and European markets. (Maybe that's why "International" is in their name?

My guess on timing would be that we're looking at the 3rd qtr or even the 4th qtr. I say that because this company hasn't shown that they are in a hurry! I think that's a fair assessment but I could be wrong. GL

Just some movement- business model sounds interesting but need to get it going. 

Whats wrong with AI as a business model?

They need better business and ai use

Yes it’s frustrating. This type of set up and management (on paper) would’ve historically fired out update and PR after PR, resulting in a huge (and fast) run up.
My only thought, predicated on patience and presumption, that in lieu of nonstop (albeit any, really) updates, there’s a better chance of something material going on. If so, the run up may prove to have more support, and therefore a longer, healthier run and hold.
Of course, pie in the sky. But it seems like recently, CDEL has been positioning L2 as an anchor and ceiling.
But it’s all squat if we don’t get some substance. Would like to see them lean into the AI rush; all indicators appear that they could make it fun and bring back some of OTC zest we’ve all been missing…
Happy Thoughts…

No faith in management

Pie in the sky.Who knows anymore. 

Prepping for what?

Well still seems like it’s prepping Who knows 

Back to reality

Back to reality

That pie in the sky!

Got to love seeing that 1.47 on L2 ask.
Unicorn baby!

Yep I agree. The chart looks great…

https://stockcharts.com/c-sc/sc?s=SYIN&p=D&yr=0&mn=6&dy=0&i=t3426261496c&r=1778171078398

I know the OTC hasn't been what it was, but this has a chance to be a Unicorn, IMO!

I know the OTC hasn't been what it was, but this has a chance to be a Unicorn, IMO!

Something’s brewing here

Hmmmm?!? 

Nice- seemed like L2 was shifting a bit yesterday. Maybe something finally coming.

A good article and a good read.  Thanks for posting.

From the article below:

“By April 2026, an Australian clinical trial had been launched, aimed specifically at earlier detection of major medical depression and PTSD.”

“…there is something in the trajectory of this company, in the speed and seriousness of the partnerships forming around it, in the clinical trials now underway in Australia…”

Also:

“A growing network of partners and affiliates…. including GENIEXO Aesthetic Research, Nuu Mobile, RaDoTech, and Tech for Troops.”